anyone else notice endpoint kicking in around week 19
Genuinely asking, not being difficult. Everyone in c/compounding repeats that hazard ratio is important. I believe it, but I have never seen anyone show why, and when I search I get 2 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true…
Titration speed is a side-effect dial far more than an efficacy dial.
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
off-label use data is different from approved-indication data
Titration speed is a side-effect dial far more than an efficacy dial.
Yes, exactly this, and it is the bit that took me 91 weeks to accept.
Is that absolute or relative risk reduction?